[August 18, 2016] |
|
Global Pituitary ACTH Hypersecretion (Cushing's Disease) Pipeline Insights Report 2016 - Research and Markets
Research and Markets has announced the addition of the "Pituitary
ACTH Hypersecretion (Cushing's Disease)-Pipeline Insights, 2016"
report to their offering.
Pituitary ACTH Hypersecretion (Cushing's Disease)-Pipeline Insights,
2016 provides in depth insights on the pipeline drugs and their
development activities around the Pituitary ACTH Hypersecretion
(Cushing's Disease). The report covers the product profiles in various
stages of development including Discovery, Pre-clinical, IND, Phase I,
Phase II, Phase III and Preregistration.
Report covers the product clinical trials information and other
development activities including technology, licensing, collaborations,
acquisitions, fundings, patent and USFDA & EMA (News - Alert) designations details.
The report also provides detailed information on the discontinued and
dormant drugs that have gone inactive over the years for Pituitary ACTH
Hypersecretion (Cushing's Disease).
The report also assesses the Pituitary ACTH Hypersecretion (Cushing's
Disease) therapeutics by Monotherapy, Combination products, molecule
type and Route of Administration.
Scope
-
The report provides competitive pipeline landscape of Ptuitary ACTH
Hypersecretion (Cushing's Disease)
-
The report provides pipeline products under drug profile section which
includes product description, MOA, licensors & collaborators,
development partner and chemical information
-
Coverage of the Pituitary ACTH Hypersecretion (Cushing's Disease)
pipeline on the basis of target, MOA, route of administration,
technology involved and molecule type
-
The report reviews key players involved in the therapeutics
development for Pituitary ACTH Hypersecretion (Cushing's Disease) and
also provide company profiling
-
The report also gives the information of dormant and discontinued
pipeline projects
-
Pipeline products coverage based on various stages of development
ranging from preregistration till discovery and undisclosed stages
-
Provides pipeline assessment by monotherapy and combination therapy
products, stage of development and molecule type
Key Topics Covered:
-
Overview
-
Pipeline Therapeutics
-
Therapeutics under Development by Companies
-
Filed and Phase III Products
-
Comparative Analysis
-
Phase II Products
-
Comparative Analysis
-
Phase I and IND Filed Products
-
Comparative Analysis
-
Discovery and Pre-Clinical Stage Products
-
Comparative Analysis
-
Drug Candidate Profiles
-
Therapeutics Assessment
-
Assessment by Monotherapy Products
-
Assessment by Combination Products
-
Assessment by Route of Administration
-
Assessment by Molecule Type
-
Discontinued Products
-
Dormant Products
-
Companies Involved in Therapeutics Development
For more information about this report visit http://www.researchandmarkets.com/research/w7mdsh/pituitary_acth
Related Topics: Endocrine
and Metabolic Disorder Drugs
View source version on businesswire.com: http://www.businesswire.com/news/home/20160818005544/en/
[ Back To TMCnet.com's Homepage ]
|